Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/3/2025

Hematuria Evaluation and Management

Initial Diagnostic Approach

  • The American Academy of Family Physicians recommends verifying microscopic hematuria with ≥3 RBCs per high-power field on at least two of three properly collected specimens, as dipstick alone has limited specificity (65-99%) and can yield false positives 1, 3
  • The American Family Physician suggests excluding benign transient causes: menstruation, vigorous exercise, sexual activity, viral illness, trauma, and recent urologic procedures by repeating urinalysis 48 hours after cessation 1, 3

Quantify Proteinuria

  • Obtain 24-hour urine collection or spot urine protein-to-creatinine ratio to determine if proteinuria is significant (>500 mg/24 hours suggests glomerular disease) 1, 3
  • 1+ protein on dipstick is typically <500 mg/24 hours, but quantification is essential 3

Determine Source: Glomerular vs. Non-Glomerular

  • Look for dysmorphic RBCs (>80% suggests glomerular origin) vs. normal-shaped RBCs (>80% suggests urologic source) 1, 3
  • Red cell casts are pathognomonic for glomerular bleeding, though relatively insensitive 1, 3

Risk Stratification for Urologic Malignancy

  • High-risk features requiring immediate urologic evaluation include age >40 years, smoking history, occupational chemical exposure, history of gross hematuria, and history of urologic disorder 1, 2, 3, 4
  • If glomerular source suspected, refer to nephrology if proteinuria >1,000 mg/24 hours, proteinuria >500 mg/24 hours that is persistent or increasing, red cell casts present, predominantly dysmorphic RBCs (>80%), or elevated or rising serum creatinine 1, 3
  • If urologic source suspected or high-risk patient, complete urologic evaluation includes multiphasic CT urography, cystoscopy, and urine cytology 1, 3, 4

Follow-Up Protocol

  • If initial evaluation is negative but hematuria persists, repeat urinalysis at 6, 12, 24, and 36 months, monitor blood pressure at each visit, and consider nephrology referral if hematuria persists with development of hypertension, proteinuria, or evidence of glomerular bleeding 3, 4

Critical Pitfalls to Avoid

  • Never attribute hematuria to anticoagulation or antiplatelet therapy alone, as these medications may unmask underlying pathology but do not cause hematuria 3, 4
  • Gross hematuria requires urgent urologic referral even if self-limited, as it has 30-40% association with malignancy 4
  • 1+ proteinuria may seem minimal, but requires quantification to determine if it meets threshold for nephrology referral 1, 3

REFERENCES

2

Management of Urinalysis with Proteinuria and Hematuria [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Hematuria Evaluation and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025